Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 1-2, 2006, Pages 76-80

  Siciliano, Massimo ^a   Annicchiarico, Brigida E ^a   Lucchese, Franco ^b   Bombardieri, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetyl L carnitine; Hepatic encephalopathy; Liver cirrhosis; Visual evoked potentials

Indexed keywords

ISOTONIC SOLUTION; LEVACECARNINE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CELL FUNCTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; EVOKED VISUAL RESPONSE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; INFUSION RATE; LATENT PERIOD; LIVER CIRRHOSIS; MALE; SINGLE DRUG DOSE; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE;

ACETYLCARNITINE; ADULT; AGED; AMMONIA; EVOKED POTENTIALS, VISUAL; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 33645054302     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04327.x     Document Type: Article

References (37)

1. Blei AT Butterworth RF Hepatic encephalopathy SeminLiver Dis 1996 16 233 9
2. Ferenci P Püspök A Steindl P Current concepts in the pathophysiology of hepatic encephalopathy EurJClinInvest 1992 22 573 81
3. Butterworth RF Giuère JF Michaud J Lavoie J Pomier-Layargues G Ammonia: A key factor in the pathogenesis of hepatic encephalopathy NeurochemPathol 1987 6 1 12
4. Lockwood AH Yap EWH Wong WH Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy JCerebBlood Metab 1991 11 337 41
5. Ahl B Weissenborn K van den Hoff J et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis Hepatology 2004 40 73 9
6. Hindfeld B Plum F Duffy TE Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts JClinInvest 1977 59 386 96
7. Lai JCK Cooper AJL α-Ketoglutarate dehydrogenase complex: Kinetic properties, regional distribution and effects of inhibitors JNeurochem 1986 47 1376 86
8. Jones EA Basile AS Does ammonia contribute to increased GABA-ergic neurotransmission? MetabBrain Dis 1998 13 319 35
9. Butterworth RF Portal-systemic encephalopathy: A disorder of neuron-astrocytic metabolic trafficking DevNeurosci 1993 15 313 19
10. Neary JT Whittemore SR Zhu Q Noremberg MD Destabilization of glial fibrillary acidic protein mRNA in astrocytes by ammonia and protection by extracellular ATP JNeurochem 1994 63 2021 7
11. Atanassov CL Muller CD Sarhan S Knodgen B Rebel G Seiler N Effect of ammonia on endocytosis, cytokine production and lysosomal enzyme activity of a microglial cell line ResImmunol 1994 145 277 88
12. Blei AT Olafsson S Therrien G Buttherworth RF Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis Hepatology 1994 19 1437 44
13. Rodrigo R Montoliu C Chatauret N et al. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease NeurochemInt 2004 45 947 53
14. O'Connor JE Costell M Grisolia S Prevention of ammonia toxicity by l -carnitine: Metabolic changes in brain NeurochemRes 1984 9 563 70
15. Matsuoka M Igisu H Comparison of the effects of l -carnitine, d -carnitine and acetyl-carnitine on the neurotoxicity of ammonia BiochemPharmacol 1993 46 159 64
16. Therrien G Rose C Butterworth J Butterworth RF Protective effect of l -carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat Hepatology 1997 25 551 6
17. Felipo V Minana MD Cabedo H Grisolia S l -Carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity NeurochemRes 1994 19 373 7
18. Felipo V Hermenegildo C Montoliu C Llansola M Minana MB Neurotoxicity of ammonia and glutamate: Molecular mechanism and prevention Neurotoxicology 1998 1975 81
19. Malaguarnera M Pistone G Astuto M et al. l -Carnitine in the treatment of mild or moderate hepatic encephalopathy DigDis 2003 21 271 5
20. Ferenci P Lockwood A Mullen K et al. Hepatic encephalopathy: Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th Word Congresses of Gastroenterology, Vienna, 1998 Hepatology 2002 35 716 21
21. Harding GFA Odom JV Spileers W Spekreuse H Standard for visual evoked potentials 1995 Vision Res 1996 36 3567 72
22. Lucchese F Mecacci L Visual evoked potentials and heart rate during white noise stimulation IntJNeurosci 1999 97 109 14
23. Cohen J Statistical Power Analysis for the Behavioural Sciences Lawrence Erlbaum Hillsdale, NJ 1988
24. Chu NS Yang SS Liaw YF Evoked potentials in liver diseases JGastroenterolHepatol 1997 12 Suppl. S288 93
25. Watanabe A Cerebral changes in hepatic encephalopathy JGastroenterolHepatol 1998 13 752 60
26. Teijeira JM Montes C Diaz E Gonzalez-Baron S Visual evoked potentials (VEP). Current perspectives RevNeurol 1998 26 451 8
27. Bombardieri G Gigli GL Bernardi L Ferri R Grassi C Milani A Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment Hepatogastroenterology 1985 32 3 7
28. Higuchi K Shimuzu Y Nambu S et al. Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testing in cirrhotic patients with mild hepatic encephalopathy JGastroenterolHepatol 1994 9 366 72
29. Grimm G Ferenci P Katzenschlager R et al. Improvement of hepatic encephalopathy treated with flumazenil Lancet 1988 ii 1392 4
30. Delgrange T Khater J Capron D Duron B Capron JP Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis GastroenterolClinBiol 1992 16 687 91
31. Amodio P Marchetti P Del Piccolo F et al. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: A double-blind placebo controlled study ClinPhysiol 1997 17 533 9
32. Seki K Nakasato N Fujita S et al. Neuromagnetic evidence that the P100 component of the pattern reversal visual evoked response originates in the bottom of the calcarine fissure ElectroencephalogrClinNeurophysiol 1996 100 436 42
33. Matsuoka M Igisu H Kohriyama K Inoue N Suppression of neurotoxicity of ammonia by l -carnitine Brain Res 1991 567 328 31
34. Bellei M Battelli D Guarriero DM et al. Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine BiochemBiophysResCommun 1989 158 181 8
35. Cooper AJL Plum F Biochemistry and physiology of brain ammonia PhysiolRev 1987 67 440 519
36. Fuller RK Hoppel CL Elevated plasma carnitine in hepatic cirrhosis Hepatology 1983 3 554 8
37. Krahenbuhl S Reichen J Carnitine metabolism in patients with chronic liver disease Hepatology 1997 25 148 53